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Cooperation  between  different  lymphoid  cell  populations,  thymus-derived  (T) 
and non-thymus-derived (B)  cells, in the optimal immune response to various anti- 
gens has become a well-established fact in recent years (1). 
Hapten-carrier studies (2, 3) indicate that this cooperation may depend on a  close 
physical contact between the  two cell types, each one recognizing specific determi- 
nants on an antigenic molecule. The detailed mechanisms behind the synergism have, 
however,  remained  relatively unclear.  The  most  popular theories about  the  inter- 
action between T  and B  cells include (a) the concentration of antigen on the surface 
of the T  cell and presentation to the B cell (2) and (b) the production of soluble factors 
by T  cells upon contact with their specific antigens, which in turn would stimulate the 
linked B cell. in the last model, both nonspecific (4-6) and antigen-specific (7) factors 
have  been  suggested to play a  role. The  involvement of an  antigen-specific T  cell 
factor would, however, require the participation of a third-party cell, e.g., macrophages 
(7). Using the Mishell-Dutton in vitro system of mouse lymphoid cells for antibody 
production against various heterologous red blood cells (8), we have undertaken to 
study the mechanisms involved. 
We have established that in this system the 19S response against sheep red blood 
cells (SRBC)  is highly T  cell dependent, since it can be abrogated by treatment of 
spleen cells with antitheta serum and complement (9). Complete reconstitution of the 
response  can  be  achieved  by  antigen-activated T  cells  (10),  by allogeneic T  cells 
(11), and also and most interestingly by a  soluble T  cell-replacing factor (4)  (TRF). 
TRF can be obtained from spleen cells, lymph node cells, and thymus cells (12)  sub- 
jected to heavy stimulation by transplantation antigens unrelated, to the best of our 
knowledge, to the antigens used in the test system, namely sheep, horse, and chicken 
red blood cells. TRF production has been shown to be dependent on the presence of 
T  cells (4) and to be nonantigen specific also in its stimulatory function by al  1 criteria 
applied (12). The factor can fully replace T  cell function for the antigens use d under 
the  most  stringent conditions of T  cell depletion in  spleen cultures  from  the  con- 
genitally athymic nude mice (13), even after treatment with anti-~-serum and comple- 
ment. We have therefore suggested that TRF is a physiological product in all normal 
T-B cell contacts and that the proximity of T  and B  cells is necessary to assure that 
TRF can be transferred from the T  cell to the B cell (4). Soluble products with similar 
properties have recently been described by various groups (5,  14). 
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In order to support the notion that TRF has some physiological role to play, 
it would be desirable to show that TRF can stimulate not only IgM (19S) but 
also IgG (7S)  responses, since the latter are even more strikingly dependent on 
T  cell function (15)  and, moreover, physiologically more important. This com- 
munication shows that an IgG (7S)  response to SRBC can be obtained by add- 
ing TRF to T cell-deprived spleen cultures of preimmunized mice (12). 
Materials and Methods 
8-12-wk  old  B6D2F1  mice  (C57BL/6J  X  DBA/2J)F~  from  Jackson  Laboratory,  Bar 
Harbor, Maine, were immunized by the intraperitoneat injection of 1 X  l0  s sheep red blood 
cells in balanced salt solution (BSS) 8, 9, and 10 days before sacrifice.  Spleen cell suspensions 
were then prepared as previously described  (8).  Removal of T  cells,  according to Raft (16), 
was achieved by simultaneous treatment of aliquots each of 3 X  107 cells with 0.5 ml of AKR 
anti-0-C3H ascitic fluid and 0.5 ml of guinea pig complement (final dilutions 1:5, respectively) 
for 30 nfin at 37°C. Controls were treated similarly but anti-0-serum was replaced by 0.5 ml 
of culture medium containing 20c~o of fetal bovine serum. 
After the incubation, the cells were washed  twice with BSS in  the cold.  They were re- 
suspended in culture medium  (8),  the cell concentration being adjusted  to  1.6  X  107 cells 
per ml. 0.5 ml of this suspension was seeded into small Petri dishes. The antigen dose usually 
consisted of 5  X  10  ~ SRBC per plate. Where required,  0.5 ml of TRF preparation  (4)  was 
added immediately, controls receiving 0.5 ml of additional culture medium instead. The plates 
were then placed on a rocker platform and incubated at 37°C in an atmosphere of 10% CO2, 
7~v 02, 83~ N2. In some experiments, 0.5 ml of medium was withdrawn after the times indi- 
cated and 0.5 ml of TRF was freshly added. 
Immune  responses were  usually assayed  at  day  4  of  culture  by  the  hemolytic  plaque 
technique of Jerne as modified by Mishell and  Dutton  (17,  8).  IgM  (19S)  producers were 
measured  as  direct  plaque formers with complement alone.  For  the demonstration of IgG 
(7S) plaques, parallel slides were incubated for 1 h with BSS and then treated for 45 rain with 
concanavalin A  (0.4  mg/ml in BSS)  according to  Nordin  et al.  (18).  Thereafter,  the slides 
were carefully washed in BSS and the plaques were developed during a  2 h incubation with 
rabbit antimouse IgG serum diluted 1:100 in 10% guinea pig serum as a  source of comple- 
ment. By this procedure, consistently less than I%  of 19S plaque-forming cells (PFC)  were 
developed when using primary cultures.  Plaque-forming cells are given as numbers per 106 
cells,  counted in a  Coulter Counter Model F  (Coulter Electronics, Inc., Hialeah, Fla.) at the 
appropriate  aperture.  The  variations between parallel cultures  were  :l:25v/c.  Each culture 
consisted of two parallel Petri dishes that were pooled and assayed on two parallel slides per 
dilution. 
RESULTS  AND  DISCUSSION 
Table  I  gives  the  results  obtained  after  culturing  spleen  cells  from  SRBC- 
primed mice. As has been shown by  Chan et al.  (10),  anti-0 treatment  of cells 
at  this  stage  of  immunization  (--8,  --9,  or  --10  days)  is  highly  effective  in 
abolishing both  the  19S  and  7S  immune  responses.  Indeed,  though  T  cell  re- 
moval from spleen cell suspensions of normal mice may  occasionally result in a 
residual  19S activity of up to 30 or 50 %  of untreated  controls, identical treat- 
ment  at  the  same  cell  and  antiserum  concentrations  consistently reduces  the 
response much  more  drastically when using cells from primed  mice.  After the 
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pletion  as  the  IgG response.  Both  responses  can,  however,  be reconstituted 
with TRF. But there are three important differences to the effects observed in 
primary cultures.  While  in primary cultures TRF acts optimally if added  at 
day 2 (4), for the stimulation of a secondary response it has to be present from 
the onset. This is shown in Tables I and II. in addition, the reconstitution of a 
TABLE I 
Restorative  Effect of TRF on the  19S and 7S Responses 
Time of priming  Treatment of spleen  cells  Supplement  day 0 
PFC/106  recovered cells 
19S  7S 
day 
Exp.  I 
Exp.  II 
Exp.  III 
8  GPC  MEM  7,250  (41)*  2,330  (110)* 
8  Anti*0 GPC  MEM  440  160 
8  Anti-0 GPC  Condit.  MEM  310  180 
8  Antl-0 GPC  TRF  5,600  1,130 
9  GPC  MEM  10,500  (90)*  7,150  (350)* 
9  Anti-0 GPC  MEM  140  120 
9  Anti-0 GPC  Condit.  MEM  150  170 
9  Anti-0 GPC  TRF  3,220  3,050 
10  GPC  MEM  5,150  (140)*  5,700  (200)* 
10  Anti-0 GPC  MEM  30  60 
10  Anti-0 GPC  Condit. MEM  30  110 
10  Anti-0 GPC  TRF  1,480  1,780 
Immunization see text. 
Condit.  MEM, culture medium  (5)  in which normal B6B2FI spleen ceils  (1 
TRF was added at day 0 of culture. 
GPC, guinea pig serum as a  source of complement. 
* Figures in parentheses: PFC/10 6 nucleated cells on day 0 of culture. 
X  107/ml) were grown for 24 h. 
TABLE  II 
Dependency on Time of Addition and Dose of the Restorative Effect of TRF 
Treatment of cells*  Supplement  Time of addition of 
supplement  to cultures 
PFC/106 recovered cells 
19S  7S 
h 
GPC  MEM  0  5,300  2,000 
Anti-0 +  GPC  MEM  0  160  220 
Anti-0 +  GPC  TRF  0, 24,  48,  72  2,450  1,820 
Anti-0 +  GPC  TRF  48  590  280 
* Spleen cells from B6D2Ft mice were put into culture 9 days after i.p. injection of 5 X  107 SRBC.  (Day 0: 
6  6  m  m  50 19S PFC/10  , 80 7S PFC/10  .) When more than one dose of 0.5 ml of TRF was added, 0.5  1 of culture  edium 
was withdrawn in order to maintain a constant cell concentration. 
secondary response by TRF seemingly needs much more of the factor than is 
required by a primary culture where one dose of TRF often results in a signifi- 
cant overshoot of the response well over control values (Table III). In contrast, 
even when TRF is added daily, the values for both the IgM and IgG producers 
in secondary cultures remain lower than those observed in controls (Table II). 
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mixtures of allogeneic spleen cells is able to reconstitute in vitro both the IgM 
and  the  IgG immune  responses  against  SRBC  in  T  cell-deprived spleen  cell 
cultures from primed mice. This fact seems to eliminate one of the arguments 
most often used against a possible physiological role of the nonspecific soluble 
product,  namely that  it  may merely enhance  a  normal  thymus-independent 
response against some components of heterologous blood cells. A 7S stimulation 
by the  allogeneic  effect has  previously been observed in  vivo by Katz  et  al. 
(19).  Nonspecific B  cell mitogens,  e.g.  lipopolysaccharide, however,  failed to 
lead to a  significant 7S response, though it did stimulate a  19S response in T- 
deprived cultures  (20).  A  greater  amount  of TRF  and  a  proper  timing with 
respect to its addition  seem to be mandatory both for the secondary 19S  and 
7S  responses.  This fits well to  the  observation that TRF is  not  absorbed by 
virgin spleen cells but is absorbed or used up after incubation with primed cells 
TABLE  III 
Unrestricted  19S Stimulation  by TRF of T  Cell-Deprived  Primary Cultures 
Treatment  of spleen cells  Supplement  day 2 
PFC/tO~ Recovered cells 
Day 4  Day 5 
Exp.  I  GPC  MEM  680  2,620 
Anti-0 GPC  MEM  70  210 
Anti-0 GPC  TRF  1,580  9,750 
Exp.  II  GPC  MEM  1,780 
Anti-0 GPC  MEM  180 
Anti-0 GPC  TRF  (a)  37,800 
Anti-0 GPC  TRF  (b)  14,600 
TRF  (a)  and  (b) are two different batches. 
(12).  All  this  is  most  easily reconciled  with  the  assumption  that  the  target 
cell for TRF is an "intermediary" or "early memory" cell that has already made 
contact  with  the  antigen  and  has  undergone  changes,  e.g.  capping  (21),  cell 
division, etc., which make it receptive to the action of TRF. Under our condi- 
tions and with the antigens so far used by us (blood cells of sheep, horse,  and 
chicken), this primary contact seems to take place even in the absence of T  cells 
or antigen-specific products of T  cells,  though  this may be different for other 
antigens.  The B  cell would thus  reach a  stage where contact with a  T  cell or 
TRF becomes mandatory for its final development into an antibody-producing 
cell. TRF might well turn out to be a differentiation factor. This concept seems 
to  be  supported  by the  recent  finding  that  a  B  memory can  be  induced  in 
thymectomized, irradiated,  bone marrow-protected mice, in spite of the seem- 
ingly total absence of antibody formation (22). 
In a primary culture it takes about 2 days for the B cell to reach the respon- 
sive  stage,  while  spleens  from immunized mice  already  contain  antigen-trig 
gered B  cells.  In addition,  it is reasonable to assume that the number of TRF 
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greatly exceeds that in primary cultures. This then would easily account for the 
increased amount of TRF  required to stimulate in vitro both the  19S and 7S 
responses in secondary cultures. 
SIYMMARY 
A  soluble factor  (TRF)  produced  by mixtures  of allogeneic mouse  spleen, 
lymph node,  and thymus cells functionally replaces T  cells in a  primary IgM 
antibody response to sheep blood cells in vitro. It is now shown that TRF  can 
also reconstitute an IgG antibody response in T  cell-deprived spleen cultures 
derived from preiimnunized mice. The optimal time of addition and the amount 
of TRF required differ between primary and secondary in vitro systems. 
We wish to thank Dr. H. Finger for the rabbit antimouse IgG serum  and Miss L. Hink 
for expert technical assistance. 
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